HomeTERN • NASDAQ
add
Terns Pharmaceuticals Inc
Previous close
$7.41
Year range
$3.26 - $11.40
Market cap
625.40M USD
Avg Volume
2.88M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 25.54M | 20.69% |
Net income | -22.74M | -27.05% |
Net profit margin | — | — |
Earnings per share | -0.31 | -24.00% |
EBITDA | -25.45M | -20.69% |
Effective tax rate | -0.27% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 225.30M | -21.12% |
Total assets | 230.88M | -20.30% |
Total liabilities | 12.20M | -21.53% |
Total equity | 218.68M | — |
Shares outstanding | 70.37M | — |
Price to book | 2.38 | — |
Return on assets | -26.73% | — |
Return on capital | -28.00% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -22.74M | -27.05% |
Cash from operations | -16.18M | -24.52% |
Cash from investing | 42.19M | 146.45% |
Cash from financing | 399.00K | -18.40% |
Net change in cash | 26.40M | 125.52% |
Free cash flow | -8.71M | -20.68% |
About
Founded
2016
Headquarters
Website
Employees
66